OmniAb (OABI) EBIT Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 58.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.45% |
| Dec 31, 2025 | 0.72% |
| Sep 30, 2025 | 8.22% |
| Jun 30, 2025 | 0.53% |
| Mar 31, 2025 | 16.45% |
| Dec 31, 2024 | 25.12% |
| Sep 30, 2024 | 2.71% |
| Jun 30, 2024 | 16.15% |
| Mar 31, 2024 | -166.80% |
| Dec 31, 2023 | -334.32% |
| Sep 30, 2023 | -36.26% |
| Jun 30, 2023 | -54.74% |
| Mar 31, 2023 | -2.80% |
| Dec 31, 2022 | 125.54% |
| Sep 30, 2022 | -8,640.23% |
| Jun 30, 2022 | -575,002.97% |
| Mar 31, 2022 | -105,512.64% |